Skip to main content
Erschienen in: AIDS and Behavior 4/2015

01.04.2015 | Original Paper

Understanding Treatment Refusal Among Adults Presenting for HIV-Testing in Soweto, South Africa: A Qualitative Study

verfasst von: Ingrid T. Katz, Janan Dietrich, Gugu Tshabalala, Thandekile Essien, Kathryn Rough, Alexi A. Wright, David R. Bangsberg, Glenda E. Gray, Norma C. Ware

Erschienen in: AIDS and Behavior | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

HIV treatment initiatives have focused on increasing access to antiretroviral therapy (ART). There is growing evidence, however, that treatment availability alone is insufficient to stop the epidemic. In South Africa, only one third of individuals living with HIV are actually on treatment. Treatment refusal has been identified as a phenomenon among people who are asymptomatic, however, factors driving refusal remain poorly understood. We interviewed 50 purposively sampled participants who presented for voluntary counseling and testing in Soweto to elicit a broad range of detailed perspectives on ART refusal. We then integrated our core findings into an explanatory framework. Participants described feeling “too healthy” to start treatment, despite often having a diagnosis of AIDS. This subjective view of wellness was framed within the context of treatment being reserved for the sick. Taking ART could also lead to unintended disclosure and social isolation. These data provide a novel explanatory model of treatment refusal, recognizing perceived risks and social costs incurred when disclosing one’s status through treatment initiation. Our findings suggest that improving engagement in care for people living with HIV in South Africa will require optimizing social integration and connectivity for those who test positive.
Literatur
6.
Zurück zum Zitat Kranzer K, Zeinecker J, Ginsberg P, Orrell C, Kalawe NN, Lawn SD, et al. Linkage to HIV care and antiretroviral therapy in Cape Town, South Africa. PLoS ONE. 2010;5(11):e13801.CrossRefPubMedCentralPubMed Kranzer K, Zeinecker J, Ginsberg P, Orrell C, Kalawe NN, Lawn SD, et al. Linkage to HIV care and antiretroviral therapy in Cape Town, South Africa. PLoS ONE. 2010;5(11):e13801.CrossRefPubMedCentralPubMed
8.
Zurück zum Zitat Patten GE, Cox V, Stinson K, Boulle AM, Wilkinson LS. Advanced HIV disease at antiretroviral therapy (ART) initiation despite implementation of expanded ART eligibility guidelines during 2007–2012 in Khayelitsha, South Africa. Clin Infect Dis Off Publ Infect Dis Soc Am. 2014;59:456–7.CrossRef Patten GE, Cox V, Stinson K, Boulle AM, Wilkinson LS. Advanced HIV disease at antiretroviral therapy (ART) initiation despite implementation of expanded ART eligibility guidelines during 2007–2012 in Khayelitsha, South Africa. Clin Infect Dis Off Publ Infect Dis Soc Am. 2014;59:456–7.CrossRef
9.
Zurück zum Zitat Smith LR, Amico KR, Shuper PA, Christie S, Fisher WA, Cornman DH, et al. Information, motivation, and behavioral skills for early pre-ART engagement in HIV care among patients entering clinical care in KwaZulu-Natal, South Africa. AIDS Care. 2013;25:1485–90.CrossRefPubMedCentralPubMed Smith LR, Amico KR, Shuper PA, Christie S, Fisher WA, Cornman DH, et al. Information, motivation, and behavioral skills for early pre-ART engagement in HIV care among patients entering clinical care in KwaZulu-Natal, South Africa. AIDS Care. 2013;25:1485–90.CrossRefPubMedCentralPubMed
10.
Zurück zum Zitat Bassett IV, Regan S, Chetty S, Giddy J, Uhler LM, Holst H, et al. Who starts antiretroviral therapy in Durban, South Africa?… not everyone who should. AIDS Lond Engl. 2010;24(Suppl 1):S37–44.CrossRef Bassett IV, Regan S, Chetty S, Giddy J, Uhler LM, Holst H, et al. Who starts antiretroviral therapy in Durban, South Africa? not everyone who should. AIDS Lond Engl. 2010;24(Suppl 1):S37–44.CrossRef
11.
Zurück zum Zitat Curran K, Ngure K, Shell-Duncan B, Vusha S, Mugo NR, Heffron R, et al. “If I am given antiretrovirals I will think I am nearing the grave”: Kenyan HIV serodiscordant couples’ attitudes regarding early initiation of antiretroviral therapy. AIDS Lond Engl. 2014;28:227–33.CrossRef Curran K, Ngure K, Shell-Duncan B, Vusha S, Mugo NR, Heffron R, et al. “If I am given antiretrovirals I will think I am nearing the grave”: Kenyan HIV serodiscordant couples’ attitudes regarding early initiation of antiretroviral therapy. AIDS Lond Engl. 2014;28:227–33.CrossRef
12.
Zurück zum Zitat Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365:493–505.CrossRefPubMedCentralPubMed Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365:493–505.CrossRefPubMedCentralPubMed
13.
Zurück zum Zitat Anglemyer A, Rutherford GW, Horvath T, Baggaley RC, Egger M, Siegfried N. Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples. Cochrane Database Syst Rev. 2013;4:CD009153.PubMedCentralPubMed Anglemyer A, Rutherford GW, Horvath T, Baggaley RC, Egger M, Siegfried N. Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples. Cochrane Database Syst Rev. 2013;4:CD009153.PubMedCentralPubMed
14.
Zurück zum Zitat Tanser F, Bärnighausen T, Grapsa E, Zaidi J, Newell M-L. High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science. 2013;339:966–71.CrossRefPubMedCentralPubMed Tanser F, Bärnighausen T, Grapsa E, Zaidi J, Newell M-L. High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science. 2013;339:966–71.CrossRefPubMedCentralPubMed
15.
Zurück zum Zitat Cloete C, Regan S, Giddy J, Govender T, Erlwanger A, Gaynes MR, et al. The linkage outcomes of a large-scale, rapid transfer of HIV-infected patients from hospital-based to community-based clinics in South Africa. Open Forum Infect Dis. 2014;1:ofu058.CrossRefPubMedCentralPubMed Cloete C, Regan S, Giddy J, Govender T, Erlwanger A, Gaynes MR, et al. The linkage outcomes of a large-scale, rapid transfer of HIV-infected patients from hospital-based to community-based clinics in South Africa. Open Forum Infect Dis. 2014;1:ofu058.CrossRefPubMedCentralPubMed
16.
Zurück zum Zitat Katz IT, Essien T, Marinda ET, Gray GE, Bangsberg DR, Martinson NA, et al. Antiretroviral refusal among newly diagnosed HIV-infected adults in Soweto, South Africa. AIDS Lond Engl. 2011;25:2177–81.CrossRef Katz IT, Essien T, Marinda ET, Gray GE, Bangsberg DR, Martinson NA, et al. Antiretroviral refusal among newly diagnosed HIV-infected adults in Soweto, South Africa. AIDS Lond Engl. 2011;25:2177–81.CrossRef
17.
Zurück zum Zitat Heffron R, Ngure K, Mugo N, Celum C, Kurth A, Curran K, et al. Willingness of Kenyan HIV-1 serodiscordant couples to use antiretroviral-based HIV-1 prevention strategies. J Acquir Immune Defic Syndr. 2012;61:116–9.CrossRefPubMedCentralPubMed Heffron R, Ngure K, Mugo N, Celum C, Kurth A, Curran K, et al. Willingness of Kenyan HIV-1 serodiscordant couples to use antiretroviral-based HIV-1 prevention strategies. J Acquir Immune Defic Syndr. 2012;61:116–9.CrossRefPubMedCentralPubMed
18.
Zurück zum Zitat Mujugira A, Celum C, Thomas KK, Farquhar C, Mugo N, Katabira E, et al. Delay of antiretroviral therapy initiation is common in East African HIV-infected individuals in serodiscordant partnerships. J Acquir Immune Defic Syndr. 2014;66:436–42.CrossRefPubMed Mujugira A, Celum C, Thomas KK, Farquhar C, Mugo N, Katabira E, et al. Delay of antiretroviral therapy initiation is common in East African HIV-infected individuals in serodiscordant partnerships. J Acquir Immune Defic Syndr. 2014;66:436–42.CrossRefPubMed
19.
Zurück zum Zitat Nachega JB, Uthman OA, del Rio C, Mugavero MJ, Rees H, Mills EJ. Addressing the Achilles’ heel in the HIV care continuum for the success of a test-and-treat strategy to achieve an AIDS-free generation. Clin Infect Dis. 2014;59:S21–7.CrossRefPubMed Nachega JB, Uthman OA, del Rio C, Mugavero MJ, Rees H, Mills EJ. Addressing the Achilles’ heel in the HIV care continuum for the success of a test-and-treat strategy to achieve an AIDS-free generation. Clin Infect Dis. 2014;59:S21–7.CrossRefPubMed
20.
Zurück zum Zitat Geng EH, Bwana MB, Muyindike W, Glidden DV, Bangsberg DR, Neilands TB, et al. Failure to initiate antiretroviral therapy, loss to follow-up and mortality among HIV-infected patients during the pre-ART period in Uganda. J Acquir Immune Defic Syndr. 2013;63:e64–71.CrossRefPubMedCentralPubMed Geng EH, Bwana MB, Muyindike W, Glidden DV, Bangsberg DR, Neilands TB, et al. Failure to initiate antiretroviral therapy, loss to follow-up and mortality among HIV-infected patients during the pre-ART period in Uganda. J Acquir Immune Defic Syndr. 2013;63:e64–71.CrossRefPubMedCentralPubMed
21.
Zurück zum Zitat Stinson K, Myer L. Barriers to initiating antiretroviral therapy during pregnancy: a qualitative study of women attending services in Cape Town, South Africa. Afr J AIDS Res. 2012;11:65–73.CrossRef Stinson K, Myer L. Barriers to initiating antiretroviral therapy during pregnancy: a qualitative study of women attending services in Cape Town, South Africa. Afr J AIDS Res. 2012;11:65–73.CrossRef
23.
Zurück zum Zitat Meintjes G, Maartens G, Boulle A, Conradie F, Goemaere E. South African treatment guidelines. S Afr J HIV Med. 2012;13:114–33. Meintjes G, Maartens G, Boulle A, Conradie F, Goemaere E. South African treatment guidelines. S Afr J HIV Med. 2012;13:114–33.
24.
Zurück zum Zitat Creswell JW. Qualitative inquiry and research design: choosing among five traditions. 1st ed. Thousand Oaks: SAGE Publications, Inc.; 1997. Creswell JW. Qualitative inquiry and research design: choosing among five traditions. 1st ed. Thousand Oaks: SAGE Publications, Inc.; 1997.
25.
26.
Zurück zum Zitat Strauss AC, Corbin JM. Basics of qualitative research: second edition: techniques and procedures for developing grounded theory. 2nd ed. Thousand Oaks: SAGE Publications, Inc.; 1998. Strauss AC, Corbin JM. Basics of qualitative research: second edition: techniques and procedures for developing grounded theory. 2nd ed. Thousand Oaks: SAGE Publications, Inc.; 1998.
27.
Zurück zum Zitat Tversky A, Kahneman D. Judgment under uncertainty: heuristics and biases. Science. 1974;185:1124–31.CrossRefPubMed Tversky A, Kahneman D. Judgment under uncertainty: heuristics and biases. Science. 1974;185:1124–31.CrossRefPubMed
28.
Zurück zum Zitat Finucane ML, Alhakami A, Slovic P, Johnson SM. The affect heuristic in judgments of risks and benefits. J Behav Decis Mak. 2000;13:1–17.CrossRef Finucane ML, Alhakami A, Slovic P, Johnson SM. The affect heuristic in judgments of risks and benefits. J Behav Decis Mak. 2000;13:1–17.CrossRef
29.
Zurück zum Zitat Kahn TR, Desmond M, Rao D, Marx GE, Guthrie BL, Bosire R, et al. Delayed initiation of antiretroviral therapy among HIV-discordant couples in Kenya. AIDS Care. 2013;25:265–72.PubMedCentralPubMed Kahn TR, Desmond M, Rao D, Marx GE, Guthrie BL, Bosire R, et al. Delayed initiation of antiretroviral therapy among HIV-discordant couples in Kenya. AIDS Care. 2013;25:265–72.PubMedCentralPubMed
30.
Zurück zum Zitat Unge C, Johansson A, Zachariah R, Some D, Van Engelgem I, Ekstrom AM. Reasons for unsatisfactory acceptance of antiretroviral treatment in the urban Kibera slum, Kenya. AIDS Care. 2008;20:146–9.CrossRefPubMed Unge C, Johansson A, Zachariah R, Some D, Van Engelgem I, Ekstrom AM. Reasons for unsatisfactory acceptance of antiretroviral treatment in the urban Kibera slum, Kenya. AIDS Care. 2008;20:146–9.CrossRefPubMed
31.
Zurück zum Zitat Tsai AC, Bangsberg DR. The importance of social ties in sustaining medication adherence in resource-limited settings. J Gen Intern Med. 2011;26:1391–3.CrossRefPubMedCentralPubMed Tsai AC, Bangsberg DR. The importance of social ties in sustaining medication adherence in resource-limited settings. J Gen Intern Med. 2011;26:1391–3.CrossRefPubMedCentralPubMed
32.
Zurück zum Zitat Bangsberg DR, Deeks SG. Spending more to save more: interventions to promote adherence. Ann Intern Med. 2010;152:54–6; W-13. Bangsberg DR, Deeks SG. Spending more to save more: interventions to promote adherence. Ann Intern Med. 2010;152:54–6; W-13.
33.
Zurück zum Zitat Ware NC, Idoko J, Kaaya S, Biraro IA, Wyatt MA, Agbaji O, et al. Explaining adherence success in sub-Saharan Africa: an ethnographic study. PLoS Med. 2009;6:e1000011.CrossRefPubMedCentral Ware NC, Idoko J, Kaaya S, Biraro IA, Wyatt MA, Agbaji O, et al. Explaining adherence success in sub-Saharan Africa: an ethnographic study. PLoS Med. 2009;6:e1000011.CrossRefPubMedCentral
34.
Zurück zum Zitat Weiser SD, Tuller DM, Frongillo EA, Senkungu J, Mukiibi N, Bangsberg DR. Food insecurity as a barrier to sustained antiretroviral therapy adherence in Uganda. PLoS ONE. 2010;5:e10340.CrossRefPubMedCentralPubMed Weiser SD, Tuller DM, Frongillo EA, Senkungu J, Mukiibi N, Bangsberg DR. Food insecurity as a barrier to sustained antiretroviral therapy adherence in Uganda. PLoS ONE. 2010;5:e10340.CrossRefPubMedCentralPubMed
35.
Zurück zum Zitat Tuller DM, Bangsberg DR, Senkungu J, Ware NC, Emenyonu N, Weiser SD. Transportation costs impede sustained adherence and access to HAART in a clinic population in southwestern Uganda: a qualitative study. AIDS Behav. 2010;14:778–84.CrossRefPubMedCentralPubMed Tuller DM, Bangsberg DR, Senkungu J, Ware NC, Emenyonu N, Weiser SD. Transportation costs impede sustained adherence and access to HAART in a clinic population in southwestern Uganda: a qualitative study. AIDS Behav. 2010;14:778–84.CrossRefPubMedCentralPubMed
36.
Zurück zum Zitat Tsai AC, Bangsberg DR, Emenyonu N, Senkungu JK, Martin JN, Weiser SD. The social context of food insecurity among persons living with HIV/AIDS in rural Uganda. Soc Sci Med. 1982;2011(73):1717–24. Tsai AC, Bangsberg DR, Emenyonu N, Senkungu JK, Martin JN, Weiser SD. The social context of food insecurity among persons living with HIV/AIDS in rural Uganda. Soc Sci Med. 1982;2011(73):1717–24.
37.
Zurück zum Zitat Ware NC, Wyatt MA, Tugenberg T. Social relationships, stigma and adherence to antiretroviral therapy for HIV/AIDS. AIDS Care. 2006;18:904–10.CrossRefPubMed Ware NC, Wyatt MA, Tugenberg T. Social relationships, stigma and adherence to antiretroviral therapy for HIV/AIDS. AIDS Care. 2006;18:904–10.CrossRefPubMed
38.
Zurück zum Zitat Samuels FA, Rutenberg N. “Health regains but livelihoods lag”: findings from a study with people on ART in Zambia and Kenya. AIDS Care. 2011;23:748–54.CrossRefPubMed Samuels FA, Rutenberg N. “Health regains but livelihoods lag”: findings from a study with people on ART in Zambia and Kenya. AIDS Care. 2011;23:748–54.CrossRefPubMed
39.
Zurück zum Zitat Izugbara CO, Wekesa E. Beliefs and practices about antiretroviral medication: a study of poor urban Kenyans living with HIV/AIDS. Sociol Health Illn. 2011;33:869–83.CrossRefPubMed Izugbara CO, Wekesa E. Beliefs and practices about antiretroviral medication: a study of poor urban Kenyans living with HIV/AIDS. Sociol Health Illn. 2011;33:869–83.CrossRefPubMed
42.
Zurück zum Zitat Kalichman SC, Simbayi LC, Jooste S, Toefy Y, Cain D, Cherry C, et al. Development of a brief scale to measure AIDS-related stigma in South Africa. AIDS Behav. 2005;9:135–43.CrossRefPubMed Kalichman SC, Simbayi LC, Jooste S, Toefy Y, Cain D, Cherry C, et al. Development of a brief scale to measure AIDS-related stigma in South Africa. AIDS Behav. 2005;9:135–43.CrossRefPubMed
43.
Zurück zum Zitat Wolfe WRW, Weiser SD, Bangsberg DR, Thior I, Makhema JM, Dickinson DB, Mompati KF, Marlink RG. Effects of HIV-related stigma among an early sample of patients receiving antiretroviral therapy in Botswana. AIDS Care. 2006;18:931–3.CrossRefPubMed Wolfe WRW, Weiser SD, Bangsberg DR, Thior I, Makhema JM, Dickinson DB, Mompati KF, Marlink RG. Effects of HIV-related stigma among an early sample of patients receiving antiretroviral therapy in Botswana. AIDS Care. 2006;18:931–3.CrossRefPubMed
44.
Zurück zum Zitat Roura M, Urassa M, Busza J, Mbata D, Wringe A, Zaba B. Scaling up stigma? The effects of antiretroviral roll-out on stigma and HIV testing. Early evidence from rural Tanzania. Sex Transm Infect. 2009;85:308–12.CrossRefPubMedCentralPubMed Roura M, Urassa M, Busza J, Mbata D, Wringe A, Zaba B. Scaling up stigma? The effects of antiretroviral roll-out on stigma and HIV testing. Early evidence from rural Tanzania. Sex Transm Infect. 2009;85:308–12.CrossRefPubMedCentralPubMed
45.
Zurück zum Zitat Mansergh G, Marks G, Simoni JM. Self-disclosure of HIV infection among men who vary in time since seropositive diagnosis and symptomatic status. AIDS Lond Engl. 1995;9:639–44.CrossRef Mansergh G, Marks G, Simoni JM. Self-disclosure of HIV infection among men who vary in time since seropositive diagnosis and symptomatic status. AIDS Lond Engl. 1995;9:639–44.CrossRef
46.
Zurück zum Zitat Hays RB, McKusick L, Pollack L, Hilliard R, Hoff C, Coates TJ. Disclosing HIV seropositivity to significant others. AIDS Lond Engl. 1993;7:425–31.CrossRef Hays RB, McKusick L, Pollack L, Hilliard R, Hoff C, Coates TJ. Disclosing HIV seropositivity to significant others. AIDS Lond Engl. 1993;7:425–31.CrossRef
47.
Zurück zum Zitat Patel R, Ratner J, Gore-Felton C, Kadzirange G, Woelk G, Katzenstein D. HIV disclosure patterns, predictors, and psychosocial correlates among HIV positive women in Zimbabwe. AIDS Care. 2012;24:358–68.CrossRefPubMedCentralPubMed Patel R, Ratner J, Gore-Felton C, Kadzirange G, Woelk G, Katzenstein D. HIV disclosure patterns, predictors, and psychosocial correlates among HIV positive women in Zimbabwe. AIDS Care. 2012;24:358–68.CrossRefPubMedCentralPubMed
48.
Zurück zum Zitat Alonzo AA, Reynolds NR. Stigma, HIV and AIDS: an exploration and elaboration of a stigma trajectory. Soc Sci Med. 1982;1995(41):303–15. Alonzo AA, Reynolds NR. Stigma, HIV and AIDS: an exploration and elaboration of a stigma trajectory. Soc Sci Med. 1982;1995(41):303–15.
49.
Zurück zum Zitat Nam SL, Fielding K, Avalos A, Dickinson D, Gaolathe T, Geissler PW. The relationship of acceptance or denial of HIV-status to antiretroviral adherence among adult HIV patients in urban Botswana. Soc Sci Med. 1982;2008(67):301–10. Nam SL, Fielding K, Avalos A, Dickinson D, Gaolathe T, Geissler PW. The relationship of acceptance or denial of HIV-status to antiretroviral adherence among adult HIV patients in urban Botswana. Soc Sci Med. 1982;2008(67):301–10.
50.
Zurück zum Zitat Green HD, Atuyambe L, Ssali S, Ryan GW, Wagner GJ. Social networks of PLHA in Uganda: implications for mobilizing PLHA as agents for prevention. AIDS Behav. 2011;15:992–1002.CrossRefPubMedCentralPubMed Green HD, Atuyambe L, Ssali S, Ryan GW, Wagner GJ. Social networks of PLHA in Uganda: implications for mobilizing PLHA as agents for prevention. AIDS Behav. 2011;15:992–1002.CrossRefPubMedCentralPubMed
51.
Zurück zum Zitat Guthrie BL, Choi RY, Liu AY, Mackelprang RD, Rositch AF, Bosire R, et al. Barriers to antiretroviral initiation in HIV-1-discordant couples. J Acquir Immune Defic Syndr. 1999;2011(58):e87–93. Guthrie BL, Choi RY, Liu AY, Mackelprang RD, Rositch AF, Bosire R, et al. Barriers to antiretroviral initiation in HIV-1-discordant couples. J Acquir Immune Defic Syndr. 1999;2011(58):e87–93.
52.
Zurück zum Zitat Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009;373:48–57.CrossRefPubMed Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009;373:48–57.CrossRefPubMed
53.
Zurück zum Zitat Hayes R, Ayles H, Beyers N, Sabapathy K, Floyd S, Shanaube K, et al. HPTN 071 (PopART): rationale and design of a cluster-randomised trial of the population impact of an HIV combination prevention intervention including universal testing and treatment—a study protocol for a cluster randomised trial. Trials. 2014;15:57.CrossRefPubMedCentralPubMed Hayes R, Ayles H, Beyers N, Sabapathy K, Floyd S, Shanaube K, et al. HPTN 071 (PopART): rationale and design of a cluster-randomised trial of the population impact of an HIV combination prevention intervention including universal testing and treatment—a study protocol for a cluster randomised trial. Trials. 2014;15:57.CrossRefPubMedCentralPubMed
Metadaten
Titel
Understanding Treatment Refusal Among Adults Presenting for HIV-Testing in Soweto, South Africa: A Qualitative Study
verfasst von
Ingrid T. Katz
Janan Dietrich
Gugu Tshabalala
Thandekile Essien
Kathryn Rough
Alexi A. Wright
David R. Bangsberg
Glenda E. Gray
Norma C. Ware
Publikationsdatum
01.04.2015
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 4/2015
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-014-0920-y

Weitere Artikel der Ausgabe 4/2015

AIDS and Behavior 4/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.